Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Feb 02, 2020 9:14pm

82 Views

Post# 30631912

RE:RE:RE:RE:RE:RE:RE:RE:Qwerty and JFM - love to hear what you think about this

It's certainly not helping TaiMed ... they hit a new 52 week low this evening.

-LT

SPCEO1 wrote: There is tiny, tiny, tiny (did I mention it's tiny) chance that the potential HIV aspect of coronavirus could have an impact on TH's stock price simply because Trogarzo is an HIV drug and the silly market may react by bidding all such stocks higher. But, that is not likely.

Bucknelly21 wrote: I'm having a hard time trying to understand what the point of analyzing this particular situation is?